CORTEXYME

cortexyme-logo

Cortexyme is a clinical stage pharmaceutical company developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is currently testing several potential lead therapeutics in preclinical studies.

#SimilarOrganizations #People #Financial #Event #Website #More

CORTEXYME

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
2012-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.cortexyme.com

Total Employee:
11+

Status:
Active

Total Funding:
225 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome


Similar Organizations

bionpharma-logo

BionPharma

BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.

clene-nanomedicine-logo

Clene Nanomedicine

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

dyne-therapeutics-logo

Dyne Therapeutics

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montrรฉal and Lรฉvis.

praxis-precision-medicines-logo

Praxis Precision Medicines

Praxis Precision Medicines offers drug development services.

theravance-biopharma-logo

Theravance Biopharma

Theravance Biopharma is a biopharmaceutical company with one approved product.

tiburio-therapeutics-logo

Tiburio Therapeutics

Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.


Current Advisors List

christopher-senner_image

Christopher Senner Board Member @ Cortexyme
Board_member
2019-03-01

margi-mcloughlin_image

Margi McLoughlin Board Member @ Cortexyme
Board_member
2015-01-01

kevin-young_image

Kevin Young Board Member @ Cortexyme
Board_member
2019-02-01

not_available_image

David Lamond Board Member @ Cortexyme
Board_member

stephen-dominy_image

Stephen Dominy Board Member @ Cortexyme
Board_member
2015-12-01

casey-lynch_image

Casey Lynch Board Chairman @ Cortexyme
Board_member
2013-01-01

una-ryan_image

Una Ryan Board Member @ Cortexyme
Board_member
2019-01-01

Current Employees Featured

casey-lynch_image

Casey Lynch
Casey Lynch Co-Founder & CEO @ Cortexyme
Co-Founder & CEO
2013-01-01

robert-galemmo_image

Robert Galemmo
Robert Galemmo VP Drug Discovery @ Cortexyme
VP Drug Discovery
2017-01-01

stephen-dominy_image

Stephen Dominy
Stephen Dominy Chief Scientific Officer @ Cortexyme
Chief Scientific Officer
2016-04-01

christopher-lowe_image

Christopher Lowe
Christopher Lowe CFO @ Cortexyme
CFO
2019-01-01

michael-detke_image

Michael Detke
Michael Detke Chief Medical Officer @ Cortexyme
Chief Medical Officer
2018-12-01

not_available_image

Caryn McDowell
Caryn McDowell Chief Legal and Administrative Officer and Corporate Secretary @ Cortexyme
Chief Legal and Administrative Officer and Corporate Secretary
2020-05-01

Founder


casey-lynch_image

Casey Lynch

not_available_image

Kristen Gafric

stephen-dominy_image

Stephen Dominy

Stock Details


Company's stock symbol is NASDAQ:CRTX

Acquisitions List

Date Company Article Price
2022-05-10 Novosteo Novosteo acquired by Cortexyme N/A

Investors List

kg-investments_image

KG Investments

KG Investments investment in Post-IPO Equity - Cortexyme

smallcap-world-fund_image

Smallcap World Fund

Smallcap World Fund investment in Series B - Cortexyme

vulcan-capital_image

Vulcan Capital

Vulcan Capital investment in Series B - Cortexyme

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Series B - Cortexyme

breakoutventures_image

Breakout Ventures

Breakout Ventures investment in Series B - Cortexyme

huizenga-capital-management_image

Huizenga Capital Management

Huizenga Capital Management investment in Series B - Cortexyme

dolby-family-ventures_image

Dolby Family Ventures

Dolby Family Ventures investment in Series B - Cortexyme

epiq-capital-group_image

EPIQ Capital Group

EPIQ Capital Group investment in Series B - Cortexyme

lamond-family_image

Lamond Family

Lamond Family investment in Series B - Cortexyme

verily-2_image

Verily

Verily investment in Series B - Cortexyme

Official Site Inspections

http://www.cortexyme.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.92 K

  • Host name: s3-website-us-west-1.amazonaws.com
  • IP address: 52.219.216.91
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Cortexyme" on Search Engine